The goal of this project is to develop STC trastuzumab, a generic version of herceptin. Trastuzumab is a monoclonal antibody made against the HER2 protein that is overexpressed in 20-25% of patients…

Ended Definitive Contract Awarded

Contract number
HHSN261201000095C
Awardee
Awarding agency
Obligated
$299,881

Award facts

Contract value 100% obligated
$299,881.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 7 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Cambridge, MA 02139, USA

Award details come from SAM.gov/FPDS.

Description

As the agency reported it.

The goal of this project is to develop STC trastuzumab, a generic version of herceptin. Trastuzumab is a monoclonal antibody made against the HER2 protein that is overexpressed in 20-25% of patients with breast cancer. Because of very high cost associated with prescribing herceptin, a generic version of this drug would make cancer treatment more affordable to a wider segment of the population and lower the cost burden on government-sponsored healthcare programs.

Quick answers

Who was awarded contract HHSN261201000095C?

HHSN261201000095C was awarded to STC Biologics, Inc. by National Cancer Institute (National Institutes of Health) on September 22, 2010.

How much is contract HHSN261201000095C worth?

The government has obligated $299,881 on HHSN261201000095C.

Was contract HHSN261201000095C competed?

The extent of competition for HHSN261201000095C was full and open competition after exclusion of sources. The government received 7 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login